NCT04583345 is a clinical trial of Questionnaires in Hypertension, sponsored by Ebru Calik Kutukcu.

Who is sponsoring NCT04583345?

NCT04583345 is sponsored by Ebru Calik Kutukcu.

What drugs are being tested in NCT04583345?

Interventions in NCT04583345: Questionnaires.

What condition does NCT04583345 study?

NCT04583345 studies Hypertension, Social Isolation, COVID.

Is NCT04583345 still recruiting?

NCT04583345 is currently completed. Last updated 23 September 2021.

Last reviewed 2021-09-23 · How we verify

NCT04583345

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Physical Activity Levels of Hypertensive and Healthy Individuals Under Social Isolation During the COVID-19 Pandemic

Completed Last updated 23 September 2021

What this trial tests

trial testing Questionnaires in Hypertension in 80 participants. Completed in 1 September 2021.

Timeline

1 June 2020

Primary endpoint
1 September 2021

1 September 2021

Quick facts

Lead sponsor	Ebru Calik Kutukcu
Status	Completed
Study type	OBSERVATIONAL
Enrollment	80
Start date	1 June 2020
Primary completion	1 September 2021
Estimated completion	1 September 2021
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

Questionnaires

Conditions studied

Hypertension — all drugs for Hypertension →
Social Isolation — all drugs for Social Isolation →
COVID — all drugs for COVID →

Sponsor

Ebru Calik Kutukcu

Who can join

Adults 18 to 65, any sex, with Hypertension or Social Isolation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

COVID-19 is an emergency situation which broke out from China in 2020. Health commitees and goverment set some rules and limit people's freedom to leave from their houses and it is called as 'social isolation'.Staying at home and disease bring about sedentary lifestyle, anxiety and depression and changed eating habits of all person. Hypertension is an important cardiovasculary risk factor and physical activity, stress managament are very important for disease control. In that study we aimed to assess hypertensive and healthy person's anxiety level, physical activity and qualit of life level during COVID-19 social isolation.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Hypertension and COVID-19: Updates from the era of vaccines and variants.
Swamy S, Koch CA, Hannah-Shmouni F, Schiffrin EL, et al · · 2022 · cited 10× · PMID 34900602 · DOI 10.1016/j.jcte.2021.100285
The Impact of Government Lockdowns on the Mental Health of the General Population: A Systematic Review and Meta-analysis.
Okazaki Y, Tsujimoto Y, Yamada K, Saka N, et al · · 2025 · PMID 40453305 · DOI 10.7759/cureus.83249

Verify or expand the search:

Other recruiting trials for Hypertension

Currently open trials in the same condition.

NCT07413159 — The "Check, Monitor, Control Hypertension" Study is a 24-month Randomized Trial in Houston Targeting African Americans A · NA · recruiting
NCT07361276 — Observational Study That Will Evaluate Treatment Patterns in the Management of Hypertension in the Public Primary Care S · recruiting
NCT07238556 — A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors · NA · recruiting
NCT07238400 — Cardiac Effects of Mineralocorticoid Receptor Antagonism After Preeclampsia · Phase 2 · recruiting
NCT07135505 — Early Time-Restricted Eating in Older Adults With Hypertension · NA · recruiting

Other Ebru Calik Kutukcu trials

Trials by the same sponsor.

NCT06087172 — Validity of 6 Minutes Stepper Test in Hypertension · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04583345 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ebru Calik Kutukcu
Last refreshed: 23 September 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04583345.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing